» Articles » PMID: 36674644

Preparation and In Vitro Characterization of Magnetic CS/PVA/HA/pSPIONs Scaffolds for Magnetic Hyperthermia and Bone Regeneration

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Jan 21
PMID 36674644
Authors
Affiliations
Soon will be listed here.
Abstract

Conventional bone cancer treatment often results in unwanted side effects, critical-sized bone defects, and inefficient cancer-cell targeting. Therefore, new approaches are necessary to better address bone cancer treatment and patient's recovery. One solution may reside in the combination of bone regeneration scaffolds with magnetic hyperthermia. By incorporating pristine superparamagnetic iron oxide nanoparticles (pSPIONs) into additively manufactured scaffolds we created magnetic structures for magnetic hyperthermia and bone regeneration. For this, hydroxyapatite (HA) particles were integrated in a polymeric matrix composed of chitosan (CS) and poly (vinyl alcohol) (PVA). Once optimized, pSPIONs were added to the CS/PVA/HA paste at three different concentrations (1.92, 3.77, and 5.54 wt.%), and subsequently additively manufactured to form a scaffold. Results indicate that scaffolds containing 3.77 and 5.54 wt.% of pSPIONs, attained temperature increases of 6.6 and 7.5 °C in magnetic hyperthermia testing, respectively. In vitro studies using human osteosarcoma Saos-2 cells indicated that pSPIONs incorporation significantly stimulated cell adhesion, proliferation and alkaline phosphatase (ALP) expression when compared to CS/PVA/HA scaffolds. Thus, these results support that CS/PVA/HA/pSPIONs scaffolds with pSPIONs concentrations above or equal to 3.77 wt.% have the potential to be used for magnetic hyperthermia and bone regeneration.

Citing Articles

Development of Scaffolds with Chitosan Magnetically Activated with Cobalt Nanoferrite: A Study on Physical-Chemical, Mechanical, Cytotoxic and Antimicrobial Behavior.

Guedes D, Guedes G, Silva J, Silva A, Luna C, Damasceno B Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458973 PMC: 11509991. DOI: 10.3390/ph17101332.


Polysaccharide Hydroxyapatite (Nano)composites and Their Biomedical Applications: An Overview of Recent Years.

Costa W, Felix Farias A, Silva-Filho E, Osajima J, Medina-Carrasco S, Orta M ACS Omega. 2024; 9(28):30035-30070.

PMID: 39035931 PMC: 11256335. DOI: 10.1021/acsomega.4c02170.


Advances in Biomimetic Scaffolds for Hard Tissue Surgery.

Uklejewski R, Winiecki M Biomimetics (Basel). 2024; 9(5).

PMID: 38786489 PMC: 11117657. DOI: 10.3390/biomimetics9050279.


Advancements in Photothermal Therapy Using Near-Infrared Light for Bone Tumors.

Xie M, Gong T, Wang Y, Li Z, Lu M, Luo Y Int J Mol Sci. 2024; 25(8).

PMID: 38673726 PMC: 11050412. DOI: 10.3390/ijms25084139.


Magnetic Hydroxyapatite Nanoparticles in Regenerative Medicine and Nanomedicine.

Inam H, Sprio S, Tavoni M, Abbas Z, Pupilli F, Tampieri A Int J Mol Sci. 2024; 25(5).

PMID: 38474056 PMC: 10932331. DOI: 10.3390/ijms25052809.


References
1.
Paulino A . Late effects of radiotherapy for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys. 2004; 60(1):265-74. DOI: 10.1016/j.ijrobp.2004.02.001. View

2.
Zhang Y, Yang J, Zhao N, Wang C, Kamar S, Zhou Y . Progress in the chemotherapeutic treatment of osteosarcoma. Oncol Lett. 2018; 16(5):6228-6237. PMC: 6202490. DOI: 10.3892/ol.2018.9434. View

3.
Sharma A, Brand D, Fairbank J, Ye H, Lavy C, Czernuszka J . A self-organising biomimetic collagen/nano-hydroxyapatite-glycosaminoglycan scaffold for spinal fusion. J Mater Sci. 2018; 52(21):12574-12592. PMC: 6029624. DOI: 10.1007/s10853-017-1229-9. View

4.
Chan Y, Marshall W . Scaling properties of cell and organelle size. Organogenesis. 2010; 6(2):88-96. PMC: 2901812. DOI: 10.4161/org.6.2.11464. View

5.
Kharazmi A, Faraji N, Mat Hussin R, Saion E, Yunus W, Behzad K . Structural, optical, opto-thermal and thermal properties of ZnS-PVA nanofluids synthesized through a radiolytic approach. Beilstein J Nanotechnol. 2015; 6:529-36. PMC: 4362026. DOI: 10.3762/bjnano.6.55. View